
2025 was a powerful year for CAS-One IR. As it closes, we hope you can take a minute and reminisce with us some of the achievements. We have updated the % of treatments per organ, total centers and treatments, and more. Of course we have a collection of pictures as well. See the full infographic here cascination.com/en/news/cas-on…
The final Top Case of 2025 was an immediate re-ablation of an HCC in segment II. AblaSure and the re-ablation workflow helped identify, and quickly re-treat, a portion of a tumor and margin that was not met with the first try. Thanks to Marc-Antoine JEGONDAY and the team from CHU de Rennes (Rennes, FR). Read the full case report here
cascination.com/en/blog/immedi…
We end the year just below 40 publications. 2025 brought in new evidence in ECT, quantitative ablation assessment, and ultrasound vs CAS-One IR (the latter pushing LTP below 5%!). We invite you to review our full list of publications here
cascination.com/en/publications

English







































